Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Nov 30, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, offering a sustained and effective solution for managing intraocular pressure (IOP). Differing from traditional eye drops that need to be applied every day, iDose® TR is a small, implantable device engineered to release a controlled dispensation of treatment directly into the eye over an longer period. This cutting-edge approach eliminates the need for frequent dosing, greatly enhancing patient adherence and overall treatment results.

At Eye Center South, we are proud to offer iDose® TR as part of our all-encompassing glaucoma care. The device is placed during a simple and low-risk procedure, designed with your ease in mind. Once in place, it ensures a steady release of glaucoma medication, keeping IOP levels consistent and safeguarding your eyesight. Patients who have difficulty managing the demands of frequent eye drop use can benefit greatly from this next-generation treatment.



Visit for more info At Eye Center South